PT  - JOURNAL ARTICLE
AU  - Das, Ashis Kumar
AU  - Gopalan, Saji Saraswathy
TI  - Epidemiology of CoVID-19 and predictors of recovery in the Republic of Korea
AID  - 10.1101/2020.05.07.20094094
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.07.20094094
4099  - http://medrxiv.org/content/early/2020/05/11/2020.05.07.20094094.short
4100  - http://medrxiv.org/content/early/2020/05/11/2020.05.07.20094094.full
AB  - Background The recent CoVID-19 pandemic has emerged as a threat to global health. Though current evidence on the epidemiology of the disease is emerging, very little is known about the predictors of recovery.Objectives To describe the epidemiology of confirmed CoVID-19 patients in Republic of Korea and identify predictors of recovery.Materials and methods Using publicly available data for confirmed CoVID-19 cases from the Korea Centers for Disease Control and Prevention from January 20, 2020 to April 30, 2020, we undertook descriptive analyses of cases stratified by sex, age group, place of exposure, date of confirmation and province. Correlation was tested among all predictors (sex, age group, place of exposure and province) with the Pearson’s correlation coefficient. Associations between recovery from CoVID-19 and predictors were estimated using a multivariable logistic regression model.Results Majority of the confirmed cases were females (56%), from 20-29 age group (24.3%), and primarily from three provinces –– Gyeongsangbuk-do (36.9%), Gyeonggi-do (20.5%) and Seoul (17.1%). Case fatality ratio was 2.1% and 41.6% cases recovered. Older patients, patients from provinces such as Daegu, Gyeonggi-do, Gyeongsangbuk-do, Jeju-do, Jeollabuk-do and Jeollanam-do, and those contracting the disease from healthcare settings had lower recovery.Conclusions Our study adds to the very limited evidence base on potential predictors of survival among confirmed CoVID-19 cases. We call additional research to explore the predictors of recovery and support development of policies to protect the vulnerable patient groups.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external or internal funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStudy uses publicly available data from Korea CDC